1.Binns, CW, Lee, AH & Fraser, ML (2008) Tea or coffee? A case study on evidence for dietary advice. Public Health Nutr 11, 1132–1141.
2.Higdon, JV & Frei, B (2006) Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 46, 101–123.
3.Dòrea, JG & da Costa, TH (2005) Is coffee a functional food? Br J Nutr 93, 773–782.
4.Broderick, P & Benjamin, AB (2004) Caffeine and psychiatric symptoms: a review. J Okla State Med Assoc 97, 538–542.
5.Nawrot, P, Jordan, S, Eastwood, J et al. (2003) Effects of caffeine on human health. Food Addit Contam 20, 1–30.
6.Greden, JF, Fontaine, P, Lubetsky, M et al. (1978) Anxiety and depression associated with caffenism among psychiatric in-patients. Am J Psychiatry 135, 963–966.
7.Gilliland, K & Andrews, D (1981) Ad lib caffeine consumption, symptoms of caffenism and academic performance. Am J Psychiatry 138, 512–514.
8.Smith, AP (2009) Caffeine, cognitive failures and health in a non-working community sample. Hum Psychopharmacol Clin Exp 24, 29–34.
9.Hintikka, J, Tolmunen, T, Honkalampi, K et al. (2005) Daily tea drinking is associated with a low level of depressive symptoms in the Finnish general population. Eur J Epidemiol 20, 359–363.
10.James, JE & Crosbie, J (1987) Somatic and psychological health implications of heavy caffeine use. Br J Addict 82, 503–509.
11.Clementz, GL & Dailey, JW (1988) Psychotropic effects of caffeine. Am Fam Physician 37, 167–172.
12.James, JE (1991) Psychopharmacology. In Caffeine and Health, pp. 280–300 [JE James, editor]. London: Academic Press.
13.Salonen, JT (1988) Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Clin Res 20, 46–50.
14.Kaplan, GA, Roberts, RE, Camacho, TC et al. (1987) Psychosocial predictors of depression: prospective evidence from the Human Population Laboratory Studies. Am J Epidemiol 125, 206–220.
15.Roberts, RE (1981) Prevalence of depressive symptoms among Mexican Americans. J Nerv Ment Dis 169, 213–219.
16.Roberts, RE & O’ Keefe, SJ (1981) Sex differences in depression re-examined. J Health Soc Behav 22, 394–400.
17.Tolmunen, T, Hintikka, J, Ruusunen, A et al. (2004) Dietary folate and the risk of depression in Finnish middle-aged men. A prospective follow-up study. Psychother Psychosom 73, 334–339.
18.Willett, W & Stampfer, M (1998) Implications of total energy intake for epidemiologic analyses. In Nutritional Epidemiology, pp. 288–298 [W Willett, editor]. New York, NY: Oxford University Press.
19.Salonen, JT, Nyyssönen, K, Korpela, H et al. (1992) High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men. Circulation 86, 803–811.
20.Lynch, J, Helmrich, SP, Lakka, TA et al. (1996) Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men. Arch Intern Med 156, 1307–1314.
21.Hernan, MA, Takkouche, B, Caamano-Isorna, F et al. (2002) A meta-analysis of coffee drinking, cigarette smoking and the risk of Parkinson’s disease. Ann Neurol 52, 276–284.
22.Eskelinen, MH, Ngandu, T, Tuomilehto, J et al. (2009) Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. J Alzheimers Dis 16, 85–91.
23.Szekely, T (1997) Caffeine as a stimulant against suicide. Arch Intern Med 157, 243–244.
24.Kaasinen, V, Aalto, S, Nagren, K et al. (2004) Dopaminergic effects of caffeine in the human striatum and thalamus. Neuroreport 15, 281–285.
25.Ebly, EM, Schaefer, JP, Campbell, NR et al. (1998) Folate status, vascular disease and cognition in elderly Canadians. Age Ageing 27, 485–491.
26.Morris, SM, Fava, M, Jacques, PF et al. (2003) Depression and folate status in the US population. Psychother Psychosom 72, 80–87.
27.Brice, CF & Smith, AP (2002) Factors associated with caffeine consumption. Int J Food Sci Nutr 53, 55–64.
28.Schwarz, B, Bischof, H-P & Kunze, M (1994) Coffee, tea and lifestyle. Prev Med 23, 377–384.
29.Minamisawa, M, Yoshida, S & Takai, N (2004) Determination of biologically active substances in roasted coffees using a diode-array HPLC system. Anal Sci 20, 325–328.
30.dos Santos, MD, Almeida, MC, Lopes, NP et al. (2006) Evaluation of the anti-inflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid. Biol Pharm Bull 29, 2236–2240.
31.Maes, M, Bosmans, E, Suy, E et al. (1991) Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production. Acta Psychiatr Scand 84, 379–386.
32.Maes, M, Meltzer, HY, Bosmans, E et al. (1995) Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 34, 301–309.
33.Sarandol, A, Sarandol, E, Eker, SS et al. (2007) Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative–antioxidative systems. Hum Psychopharmacol 22, 67–73.
34.Scalbert, A & Wiliamson, G (2000) Dietary intake of bioavailability of polyphenols. J Nutr 130, 2073–2085.
35.Natella, F, Nardini, M, Giannetti, I et al. (2002) Coffee drinking influences plasma antioxidant capacity in humans. J Agric Food Chem 50, 6211–6216.